2nd Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of The Patient Protection Affordable Care Act (P.L. 111-148) and The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152): Biosimilar provisions.

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.